Skip to main content
    A

    Alto Neuroscience, Inc. (ANRO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NYSE

    $27.14
    -2.40 (-8.12%)

    Market Cap: $1.18B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Alto Neuroscience, Inc. (ANRO) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Alto Neuroscience (ANRO) to earn -$2.49 per share in the fiscal year ending Dec 31, 2026. Of 11 analysts, 10 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 3 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 11 ratings average 2.09, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 91% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy1090.9%
    Hold19.1%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    11

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    Fiscal year ending Dec 31, 2026
    -$2.49
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$3.09
    EPS consensus

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$2.49-$2.49 to -$2.482
    Dec 31, 2027-$3.09-$4.10 to -$2.306

    Quarterly Estimates

    The EPS consensus falls from -$0.65 for the quarter ending Dec 31, 2026 to -$0.74 for the quarter ending Mar 31, 2027.

    EPS range

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.65-$0.78 to -$0.5413
    Mar 31, 2027-$0.74-$1.02 to -$0.574

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 5 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202630
    Fiscal year ending Dec 31, 202710
    Quarter ending Mar 31, 202710

    EPS Trend

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$2.49-$2.92-$2.92-$2.92-$3.17N/A
    Fiscal year ending Dec 31, 2027-$3.09-$3.19-$3.29-$3.29-$3.48N/A
    Quarter ending Mar 31, 2027-$0.74-$0.77-$0.80-$0.80-$0.80N/A

    Frequently Asked Questions About ANRO

    What is the ANRO stock forecast?

    Consensus analyst estimates put Alto Neuroscience's EPS at -$2.49 for the fiscal year ending Dec 31, 2026. The consensus rating from 11 analysts is Buy.

    How do analysts rate ANRO stock?

    Of 11 analysts covering Alto Neuroscience, 0 rate it Strong Buy, 10 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from ANRO next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.49, with estimates from -$2.49 to -$2.48 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$3.09, with estimates from -$4.10 to -$2.30 from 6 analysts.

    How many analysts cover ANRO?

    11 analysts rate Alto Neuroscience stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.